The results support the potential of TPX2 in the treatment of castration-resistant tumors and highlight the induction of apoptosis due to AIM1 and TMED3 inhibition especially in the androgen independent cancer cells (Supporting Figure S4). This evidence concerns the gene TPX2 and cancer.